Sign in

CIK 0001347178 · Accelerated filer

Vanda Pharmaceuticals Inc.

Sign in to watch
Ticker
VNDA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
030491827
Phone
202-734-3400
Business address
2200 PENNSYLVANIA AVE NW, SUITE 300E, WASHINGTON, DC, 20037
  1. S-8 Other Securities Offered to Employees in Benefit Plans
  2. EFFECT Other Notice of Effectiveness
  3. ARS Other Annual Report to Security Holders
  4. DEFA14A Proxy Proxy Materials
  5. 144 Insider Sale of Securities
  6. 144 Insider Sale of Securities
  7. 144 Insider Sale of Securities
  8. 144 Insider Sale of Securities
  9. 144 Insider Sale of Securities
  10. 144 Insider Sale of Securities
  11. 144 Insider Sale of Securities
  12. S-8 Other Securities Offered to Employees in Benefit Plans
  13. DEFA14A Proxy Proxy Materials
  14. ARS Other Annual Report to Security Holders
  15. DEFA14A Proxy Proxy Materials
  16. 144 Insider Sale of Securities
  17. 8-A12B/A Other Registration Statement
  18. 144 Insider Sale of Securities
  19. S-8 Other Securities Offered to Employees in Benefit Plans
  20. DEFA14A Proxy Proxy Materials

Page 1 of 5 · 93 filings